Evidence map›Paper›PMID 40438562›Full record

ArticleAdvances in laboratory medicine2025

Use of external quality assessment in extra-analytical phases in clinical laboratories in Spain: a survey by the Spanish Society of Laboratory Medicine (SEQC

Andrea Caballero Garralda, Immaculada Comas Reixach, Carlos García Miralles, Rubén Gómez Rioja, María Antonia Llopis Díaz, Débora Martínez Espartosa, Reyes Nicolás de Blas, Mariona Panadès Turró, Laura Puigví Fernández, Laura Rodelgo Jiménez and 2 more

Abstract read
In one paragraph

Article in Advances in laboratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea Caballero GarraldaExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Department of Clinical Biochemistry, Vall d'Hebron Hospital, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2891-6347
Immaculada Comas ReixachExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Department of Clinical Biochemistry, Vall d'Hebron Hospital, Barcelona, Spain.ORCID https://orcid.org/0000-0002-2713-8291
Carlos García MirallesExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Department of Clinical Biochemistry, Parc Tauli Hospital Universitari, Sabadell, Spain.ORCID https://orcid.org/0000-0001-5329-0070
Rubén Gómez RiojaExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Department of Laboratory Medicine, La Paz-Cantoblanco-Carlos III Hospital, Madrid, Spain.ORCID https://orcid.org/0000-0002-3429-0427
María Antonia Llopis DíazExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Catalonian Institute of Health: Barcelona, Spain.ORCID https://orcid.org/0000-0002-4789-2355
Débora Martínez EspartosaExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Department of Clinical Biochemistry, Clínica Universidad de Navarra, Madrid, Spain.ORCID https://orcid.org/0000-0002-5344-8402
Reyes Nicolás de BlasExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Department of Clinical Biochemistry, Ramón y Cajal University Hospital, Madrid, Spain.ORCID https://orcid.org/0000-0002-0701-8081
Mariona Panadès TurróExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Quality Manager-Spanish Society of Laboratory Medicine (SEQCML), Barcelona, Spain.
Laura Puigví FernándezExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Extraanalytical Head Department, Director of Operations, CLILAB Diagnòstics, Barcelona, Spain.ORCID https://orcid.org/0000-0001-6420-5353
Laura Rodelgo JiménezExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Institut of Laboratory Medicine, San Carlos Clinic Hospital, Madrid, Spain.
Berta Sufrate-VergaraExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Department of Laboratory Medicine, La Paz-Cantoblanco-Carlos III Hospital, Madrid, Spain.ORCID https://orcid.org/0000-0001-5364-3390
Emma Ventura OrriolsExtraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQCML), Extraanalytical Department of Laboratory, Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Quality indicators (QIs) are a valuable tool for monitoring and improving extra-analytical phase performance in the clinical laboratory (CL). For that reason, the Spanish Society of Laboratory Medicine (SEQC Methods: In 2023, a survey was conducted to assess the level of participation in the EQA Program, identify its potential improvements, and enhance the understanding of the collection and estimation processes of the extra-analytical QI. Results: In total, 51 % of respondents (124 responses in total) were enrolled in the program. The primary reason for participating was the need of monitoring of the extra-analytical phases (38 %). In contrast, the main reason for not taking part in the EQA Program was the difficulty in collecting data (32 %). As to potential points for improvement, 56 % considered that QI should be analyzed disaggregated by type of extraction (ambulatory vs. urgent). As many as 86 % of respondents would be interested in participating in a post-analytical phase EQA Program. Most of the suggestions about indicators to be included were related to events regarding temperature and transport times from peripheral extraction sites. Conclusions: Although interest in QIs for pre- and post-analytical phases is growing, the percentage of laboratories that collect data regularly is still limited. The findings of this survey have led the future directions for the EQA Pre-analytical Program, updating and adapting it to the current needs of CLs.

Indexed as

external quality assurance programextra-analytical phasequality indicatorssurvey

Identifiers

PMID40438562
PMCPMC12107415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.